InvestorsHub Logo

jimmybob

01/30/15 7:24 AM

#227697 RE: jimmybob #227696

Celgene price target raised to $145 from $131 at Cantor
Cantor increased its price target on Celgene, citing the strength of the company's underlying business, as well as its new product flow. The firm expects the company's EPS to trend upward through this year, and it keeps a Buy rating on the shares

nlightn

01/30/15 7:25 AM

#227699 RE: jimmybob #227696

looks like those AMZN calls will be doing nicely this morning,...nice call !!! kudo's !!!